Gene polymorphism of vascular endothelial growth factor in children with Henoch-Schonlein purpura nephritis

Chinese Journal of Contemporary Pediatrics

Volumn 11, Issue 6, 2009, Pages 417-421

  Zeng, Hua Song ^a   Xiong, Xiao Yon ^b   Chen, Yao Yong ^c   Luo, Xiao Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Guangzhou Children's Hospital   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Child; Gene polymorphism; Henoch Schonlein purpura nephritis; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN A;

ANAPHYLACTOID PURPURA; ARTICLE; BLOOD; CHILD; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; NEPHRITIS; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; GENE FREQUENCY; GENOTYPE; HUMANS; NEPHRITIS; POLYMORPHISM, GENETIC; PURPURA, SCHOENLEIN-HENOCH; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69149086064     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Topaloglu R, Sungur A, Baskin E, Besbas N, Saatci U, Bakkaloglu A. Vascular endothelial growth factor in Henoch-Schonlein purpura[J]. J Rheumatol, 2001, 28(10):2269-2273. (Pubitemid 32947874)
2. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production[J]. Cytokine, 2000, 12(8):1232-1235. (Pubitemid 30611801)
3. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes[J]. Diabetes, 2002,51(5):1635-1639. (Pubitemid 34826636)
4. Abe A, Sato K, Habuchi T, Wang L, Li Z, Tsuchiya N, et al. Single nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma[J]. Tohoku J Exp Med, 2002,198(3):181-190. (Pubitemid 36305121)
5. Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection[J]. J Am Soc Nephrol, 2002, 13(1):260-264. (Pubitemid 34042036)
6. McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer[J]. Cancer Res, 2002, 62(12):3369-3372. (Pubitemid 34651380)
7. Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma[J]. Genes Immun, 2002, 3(4):229-232. (Pubitemid 38961136)
8. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels[J]. J Vasc Res, 2000, 37(6):443-448. (Pubitemid 32037619)
9. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene[J]. Hum Immunol, 1999, 60(12):1245-1249. (Pubitemid 30017507)
10. Rueda B, Perez-Armengol C, Lopez-Lopez S, Garcia-Porrua C, Martín J, Gonzalez-Gay MA. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura[J]. J Rheumatol, 2006, 33(1):69-73. (Pubitemid 43054282)
11. Habib R, Niaudet R, Levy M. Schoenlein-Henoch purpura nephritis and IgA nephropathy [M]. //Tisher CC, Brenner BM. Renal Pathology with Clinical and Functional Correlations. 2nd ed. Philadelphia: Lippincott, 1994, 427-523.
12. Haycock GB. The nephritis of Henoch-Schoenlein purpura[M]. //Cameron JS. Oxford Textbook of Nephrology. 2nd ed. Oxford: Oxford University Press, 1998, 585-612.
13. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schoenlein-Henoch purpura nephritis[J]. Pediatr Nephrol, 1998, 12(3):238-243. (Pubitemid 28204133)
14. Watanabe T, Takahashi S, Nakajo S, Hamasaki M. Pathological improvement of IgA nephropathy and Henoch-Schoenlein purpura nephritis with urokinase therapy[J]. Acta Paediatr Japonica, 1996, 38(6):622-628. (Pubitemid 26418863)
15. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long-term prognosis of Henoch-Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura[J]. Nephrol Dial Transplant, 1997, 12(1):2277-2283.
16. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, et al. Prognosis of Henoch-Schonlein nephritis in children[J]. Br Med J, 1977, 2(6078):11-14.
17. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins[J]. Endocr Rev, 1992, 13(1):18-32.
18. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3[J]. Circulation, 1996, 93(8):1493-1495. (Pubitemid 26115412)
19. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor[J]. Endocr Rev, 1997, 18(1):4-25. (Pubitemid 27076453)
20. Rahimi N, Dayanir V, Lashkari K. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells[J]. J Biol Chem, 2000, 275(22):16986-16992. (Pubitemid 30398939)
21. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmé D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1[J]. Blood, 1996, 87(8):3336-3343. (Pubitemid 26115364)
22. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis[J]. J Biol Chem, 1996, 271(30):17629-17634. (Pubitemid 26250731)
23. Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, et al. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes[J]. Biochem Biophys Res Commun, 2005, 333(3):679-685. (Pubitemid 40854214)
24. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death[J]. Nat Genet, 2003, 34(4):383-394. (Pubitemid 36935331)
25. Bornes S, Boulard M, Hieblot C, Zanibellato C, Iacovoni JS, Prats H, et al. Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences[J]. J Biol Chem, 2004, 279(18):18717-18726. (Pubitemid 38623296)
26. Huez I, Bornes S, Bresson D, Creancier L, Prats H. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation[J]. Mol Endocrinol, 2001, 15(12):2197-2210. (Pubitemid 33141138)
27. Lambrechts D, Devriendt K, Driscoll DA, Goldmuntz E, Gewillig M, Vlietinck R, et al. Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study [J]. J Med Genet, 2005, 42(6):519-522. (Pubitemid 40847243)